Navigation Links
Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
Date:8/30/2010

ism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.

Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs.  However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union.  In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.

As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:

  1. Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
  2. Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.  
  3. Human Immunodeficiency Virus (HIV):  Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to a
    '/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Globus Medical Raises $110 Million in Series E Financing Round
11. Quark Pharmaceuticals Appoints New Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 20, 2014 /CNW Telbec/ - KLOX Technologies Inc. ... following appointments: Todd Martensen ... newly created role of Chief Commercial Officer, to oversee ... topical photoconverter gel for the treatment of chronic and ... wounds, recently approved in Europe . ...
(Date:11/21/2014)... 2014 Michael DeMarco (42) erinnert ... 14. Februar 2014 zugetragen hat. Seine Tochter Aly Demarco ... Video - http://youtu.be/5cVoMCe0uiE ... morgendliches Training zu machen", erzählt Michael DeMarco . ... begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf dem ...
(Date:11/21/2014)... , Nov. 20, 2014   Coqui RadioPharmaceuticals ... the first U.S. commercial producer of Molybdenum-99 (Mo-99), is ... with INVAP to design its Medical Isotope ... Mo-99 is the parent isotope of Technetium-99, which ... worldwide. In 2012, Congress passed legislation making it a ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2
... by March of Dimes Grantee Offers Hope for Treatment ... new gene-based,technique has successfully prevented a rare craniofacial birth ... the same disorder, according,to new research funded in part ... is being published in the journal Nature Medicine,demonstrates the ...
... /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals,Inc. (OTC Bulletin Board: ... in the People,s Republic of China ("PRC"), ... in the development of,isosorbide mononitrate sustained release ... and treatment of angina., Based on ...
Cached Medicine Technology:Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice 2Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets 2Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets 3
(Date:11/22/2014)... 22, 2014 A petition seeking a ... ) in minimally-invasive hysterectomies and fibroid removal surgeries ... end of October, Bernstein Liebhard LLP reports. According ... of November 21st, 2014. That represents an increase of ... signed on to the campaign.* , The campaign to ...
(Date:11/22/2014)... -- The wide variety and complexity of foods served ... with food allergies, an expert warns. "Every person ... food allergies that it can be really difficult to ... director of allergy and clinical immunology at Wake Forest ... "If you know you have food allergies, caution ...
(Date:11/22/2014)... New York, New York (PRWEB) November 22, 2014 ... been filed on behalf of patients who allegedly developed ... move forward in the federal multidistrict litigation now underway ... Liebhard LLP reports. According to court documents, the litigation ... at 10:00 a.m. The Court has directed Lead Counsel ...
(Date:11/22/2014)... Hastings and Hastings, a discount accident attorney in ... with the option of leaving an online review using ... and easy to navigate website that has recently been ... allows clients to research the Hastings and Hastings law ... when retaining an attorney. Those who have been injured ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Forbes ... are pleased to announce that Ashley Lombardo and ... #PayItForward contest. , Ms. Lombardo entered friend Candy ... Innovations. She wrote of how her friend is courageously ... as a single mom. Despite medical bills piling up ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2
... at the University of Southern California have pinned down ... survival trait: our ability to comprehend a sceneeven one ... The key is to process the interacting objects ... according to corresponding author Irving Biederman, professor of psychology ...
... -- Newly diagnosed cancer patients frequently face hurdles in ... to new research from the Perelman School of Medicine ... Saturday, June 4 at the 2011 annual meeting of ... with private health insurance had difficulty scheduling an appointment, ...
... kidney cancer is diagnosed in nearly 60,000 people in ... remove the affected kidney, but this procedure can be ... health problems. Unfortunately, the prognosis of kidney cancer patients ... removed and evaluated. Now, researchers at Fox Chase ...
... June 1 (HealthDay News) -- Boys and girls diagnosed ... of developing a substance abuse problem -- including cigarettes, ... which is one of the largest set of longitudinal ... association between ADHD and substance abuse found in several ...
... effect of a common anticancer drug Cisplatin is ... has some severe side effects in normal tissues, in particular ... this toxicity could identify targets for drugs that could be ... In this context, a team of researchers, led by Zheng ...
... , WEDNESDAY, June 1 (HealthDay News) -- Although the ... Swedish researchers have found that people who had them taken ... slightly greater risk of an early heart attack. ... the tonsils in the body,s immune system with the increased ...
Cached Medicine News:Health News:USC study locates the source of key brain function 2Health News:Two-thirds of newly diagnosed cancer patients unable to obtain oncology appointments 2Health News:Lymphocyte count indicates the prognosis of patients with renal cell carcinoma 2Health News:Children With ADHD More Prone to Substance Abuse: Study 2Health News:JCI online early table of contents: June 1, 2011 2Health News:JCI online early table of contents: June 1, 2011 3Health News:JCI online early table of contents: June 1, 2011 4Health News:JCI online early table of contents: June 1, 2011 5Health News:JCI online early table of contents: June 1, 2011 6Health News:JCI online early table of contents: June 1, 2011 7Health News:JCI online early table of contents: June 1, 2011 8Health News:Can Removing Tonsils, Appendix Boost Early Heart Attack Risk? 2
... offers a comprehensive array of features and ... and neonate patients, to magnetic resonance imaging ... the first MR monitor designed to meet ... patient monitoring. The new monitor is also ...
... InstaTest AFP is an immunochromatographic in vitro ... (AFP) in human serum. AFP is a ... to 74,000 D. Its normal concentration in ... are associated with hepatoma and ovarian, testicular ...
... simple and flexible solution. The Coag-A-Mate ... design, but offers full automation and ... high-volume systems. It is an easy ... also be used as a back-up ...
... is a fully automated open random ... and immunological, latex based coagulation tests. ... 5-position racks as sample carrier offers ... up to 70 reagents on-board with ...
Medicine Products: